Development and Validation of a Cuproptosis-Based Risk Score Model for Predicting Neoadjuvant Chemotherapy Response in Breast Cancer: A Transcriptomic Analysis.

Breast J · 2026 · PMC13239323 · PMID 42212700

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

borderline significancep = 0.054so close (0.05 < p ≤ 0.1)

Associations with T and N stage demonstrated borderline significance ( p = 0.054 and 0.065, respectively; Figures 5 (d) and 5 (e)).

also in 4,352 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.